img

Global Imatinib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Imatinib Drugs Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Imatinib Drugs market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Imatinib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Imatinib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Imatinib Drugs is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Imatinib Drugs include Apotex Inc., Novartis, Sanofi S.A., Cipla Inc., Mylan Pharms Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals, Actavis Generics and Dr. Reddy's Laboratories, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Imatinib Drugs, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Imatinib Drugs by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Imatinib Drugs market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Imatinib Drugs market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Apotex Inc.
Novartis
Sanofi S.A.
Cipla Inc.
Mylan Pharms Inc.
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
By Type
Capsules
Tablets
By Application
Hospitals
Drug Stores
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Imatinib Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Imatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Imatinib Drugs sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Imatinib Drugs Definition
1.2 Market by Type
1.2.1 Global Imatinib Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Capsules
1.2.3 Tablets
1.3 Market Segment by Application
1.3.1 Global Imatinib Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Imatinib Drugs Sales
2.1 Global Imatinib Drugs Revenue Estimates and Forecasts 2018-2034
2.2 Global Imatinib Drugs Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Imatinib Drugs Revenue by Region
2.3.1 Global Imatinib Drugs Revenue by Region (2018-2024)
2.3.2 Global Imatinib Drugs Revenue by Region (2024-2034)
2.4 Global Imatinib Drugs Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Imatinib Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Imatinib Drugs Sales Quantity by Region
2.6.1 Global Imatinib Drugs Sales Quantity by Region (2018-2024)
2.6.2 Global Imatinib Drugs Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Imatinib Drugs Sales Quantity by Manufacturers
3.1.1 Global Imatinib Drugs Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Imatinib Drugs Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Imatinib Drugs Sales in 2022
3.2 Global Imatinib Drugs Revenue by Manufacturers
3.2.1 Global Imatinib Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Imatinib Drugs Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Imatinib Drugs Revenue in 2022
3.3 Global Imatinib Drugs Sales Price by Manufacturers
3.4 Global Key Players of Imatinib Drugs, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Imatinib Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Imatinib Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Imatinib Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Imatinib Drugs Sales Quantity by Type
4.1.1 Global Imatinib Drugs Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Imatinib Drugs Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
4.2 Global Imatinib Drugs Revenue by Type
4.2.1 Global Imatinib Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Imatinib Drugs Forecasted Revenue by Type (2024-2034)
4.2.3 Global Imatinib Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Imatinib Drugs Price by Type
4.3.1 Global Imatinib Drugs Price by Type (2018-2024)
4.3.2 Global Imatinib Drugs Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Imatinib Drugs Sales Quantity by Application
5.1.1 Global Imatinib Drugs Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Imatinib Drugs Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
5.2 Global Imatinib Drugs Revenue by Application
5.2.1 Global Imatinib Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Imatinib Drugs Forecasted Revenue by Application (2024-2034)
5.2.3 Global Imatinib Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Imatinib Drugs Price by Application
5.3.1 Global Imatinib Drugs Price by Application (2018-2024)
5.3.2 Global Imatinib Drugs Price Forecast by Application (2024-2034)
6 North America
6.1 North America Imatinib Drugs Sales by Company
6.1.1 North America Imatinib Drugs Revenue by Company (2018-2024)
6.1.2 North America Imatinib Drugs Sales Quantity by Company (2018-2024)
6.2 North America Imatinib Drugs Market Size by Type
6.2.1 North America Imatinib Drugs Sales Quantity by Type (2018-2034)
6.2.2 North America Imatinib Drugs Revenue by Type (2018-2034)
6.3 North America Imatinib Drugs Market Size by Application
6.3.1 North America Imatinib Drugs Sales Quantity by Application (2018-2034)
6.3.2 North America Imatinib Drugs Revenue by Application (2018-2034)
6.4 North America Imatinib Drugs Market Size by Country
6.4.1 North America Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Imatinib Drugs Revenue by Country (2018-2034)
6.4.3 North America Imatinib Drugs Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Imatinib Drugs Sales by Company
7.1.1 Europe Imatinib Drugs Sales Quantity by Company (2018-2024)
7.1.2 Europe Imatinib Drugs Revenue by Company (2018-2024)
7.2 Europe Imatinib Drugs Market Size by Type
7.2.1 Europe Imatinib Drugs Sales Quantity by Type (2018-2034)
7.2.2 Europe Imatinib Drugs Revenue by Type (2018-2034)
7.3 Europe Imatinib Drugs Market Size by Application
7.3.1 Europe Imatinib Drugs Sales Quantity by Application (2018-2034)
7.3.2 Europe Imatinib Drugs Revenue by Application (2018-2034)
7.4 Europe Imatinib Drugs Market Size by Country
7.4.1 Europe Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Imatinib Drugs Revenue by Country (2018-2034)
7.4.3 Europe Imatinib Drugs Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Imatinib Drugs Sales by Company
8.1.1 China Imatinib Drugs Sales Quantity by Company (2018-2024)
8.1.2 China Imatinib Drugs Revenue by Company (2018-2024)
8.2 China Imatinib Drugs Market Size by Type
8.2.1 China Imatinib Drugs Sales Quantity by Type (2018-2034)
8.2.2 China Imatinib Drugs Revenue by Type (2018-2034)
8.3 China Imatinib Drugs Market Size by Application
8.3.1 China Imatinib Drugs Sales Quantity by Application (2018-2034)
8.3.2 China Imatinib Drugs Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Imatinib Drugs Sales by Company
9.1.1 APAC Imatinib Drugs Sales Quantity by Company (2018-2024)
9.1.2 APAC Imatinib Drugs Revenue by Company (2018-2024)
9.2 APAC Imatinib Drugs Market Size by Type
9.2.1 APAC Imatinib Drugs Sales Quantity by Type (2018-2034)
9.2.2 APAC Imatinib Drugs Revenue by Type (2018-2034)
9.3 APAC Imatinib Drugs Market Size by Application
9.3.1 APAC Imatinib Drugs Sales Quantity by Application (2018-2034)
9.3.2 APAC Imatinib Drugs Revenue by Application (2018-2034)
9.4 APAC Imatinib Drugs Market Size by Region
9.4.1 APAC Imatinib Drugs Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Imatinib Drugs Revenue by Region (2018-2034)
9.4.3 APAC Imatinib Drugs Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Imatinib Drugs Sales by Company
10.1.1 Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Imatinib Drugs Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Imatinib Drugs Market Size by Type
10.2.1 Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Imatinib Drugs Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Imatinib Drugs Market Size by Application
10.3.1 Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Imatinib Drugs Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Imatinib Drugs Market Size by Country
10.4.1 Middle East, Africa and Latin America Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Imatinib Drugs Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Apotex Inc.
11.1.1 Apotex Inc. Company Information
11.1.2 Apotex Inc. Overview
11.1.3 Apotex Inc. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Apotex Inc. Imatinib Drugs Products and Services
11.1.5 Apotex Inc. Imatinib Drugs SWOT Analysis
11.1.6 Apotex Inc. Recent Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Overview
11.2.3 Novartis Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Novartis Imatinib Drugs Products and Services
11.2.5 Novartis Imatinib Drugs SWOT Analysis
11.2.6 Novartis Recent Developments
11.3 Sanofi S.A.
11.3.1 Sanofi S.A. Company Information
11.3.2 Sanofi S.A. Overview
11.3.3 Sanofi S.A. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Sanofi S.A. Imatinib Drugs Products and Services
11.3.5 Sanofi S.A. Imatinib Drugs SWOT Analysis
11.3.6 Sanofi S.A. Recent Developments
11.4 Cipla Inc.
11.4.1 Cipla Inc. Company Information
11.4.2 Cipla Inc. Overview
11.4.3 Cipla Inc. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Cipla Inc. Imatinib Drugs Products and Services
11.4.5 Cipla Inc. Imatinib Drugs SWOT Analysis
11.4.6 Cipla Inc. Recent Developments
11.5 Mylan Pharms Inc.
11.5.1 Mylan Pharms Inc. Company Information
11.5.2 Mylan Pharms Inc. Overview
11.5.3 Mylan Pharms Inc. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Mylan Pharms Inc. Imatinib Drugs Products and Services
11.5.5 Mylan Pharms Inc. Imatinib Drugs SWOT Analysis
11.5.6 Mylan Pharms Inc. Recent Developments
11.6 Glenmark Pharmaceuticals Ltd.
11.6.1 Glenmark Pharmaceuticals Ltd. Company Information
11.6.2 Glenmark Pharmaceuticals Ltd. Overview
11.6.3 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Glenmark Pharmaceuticals Ltd. Imatinib Drugs Products and Services
11.6.5 Glenmark Pharmaceuticals Ltd. Imatinib Drugs SWOT Analysis
11.6.6 Glenmark Pharmaceuticals Ltd. Recent Developments
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Information
11.7.2 Sun Pharmaceuticals Overview
11.7.3 Sun Pharmaceuticals Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Sun Pharmaceuticals Imatinib Drugs Products and Services
11.7.5 Sun Pharmaceuticals Imatinib Drugs SWOT Analysis
11.7.6 Sun Pharmaceuticals Recent Developments
11.8 Actavis Generics
11.8.1 Actavis Generics Company Information
11.8.2 Actavis Generics Overview
11.8.3 Actavis Generics Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Actavis Generics Imatinib Drugs Products and Services
11.8.5 Actavis Generics Imatinib Drugs SWOT Analysis
11.8.6 Actavis Generics Recent Developments
11.9 Dr. Reddy's Laboratories
11.9.1 Dr. Reddy's Laboratories Company Information
11.9.2 Dr. Reddy's Laboratories Overview
11.9.3 Dr. Reddy's Laboratories Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Dr. Reddy's Laboratories Imatinib Drugs Products and Services
11.9.5 Dr. Reddy's Laboratories Imatinib Drugs SWOT Analysis
11.9.6 Dr. Reddy's Laboratories Recent Developments
11.10 Teva Pharmaceutical Industries Ltd.
11.10.1 Teva Pharmaceutical Industries Ltd. Company Information
11.10.2 Teva Pharmaceutical Industries Ltd. Overview
11.10.3 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Teva Pharmaceutical Industries Ltd. Imatinib Drugs Products and Services
11.10.5 Teva Pharmaceutical Industries Ltd. Imatinib Drugs SWOT Analysis
11.10.6 Teva Pharmaceutical Industries Ltd. Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Imatinib Drugs Value Chain Analysis
12.2 Imatinib Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Imatinib Drugs Production Mode & Process
12.4 Imatinib Drugs Sales and Marketing
12.4.1 Imatinib Drugs Sales Channels
12.4.2 Imatinib Drugs Distributors
12.5 Imatinib Drugs Customers
13 Market Dynamics
13.1 Imatinib Drugs Industry Trends
13.2 Imatinib Drugs Market Drivers
13.3 Imatinib Drugs Market Challenges
13.4 Imatinib Drugs Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Imatinib Drugs Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Capsules
Table 3. Major Manufacturers of Tablets
Table 4. Global Imatinib Drugs Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Imatinib Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Imatinib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Imatinib Drugs Revenue Market Share by Region (2018-2024)
Table 8. Global Imatinib Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Imatinib Drugs Revenue Market Share by Region (2024-2034)
Table 10. Global Imatinib Drugs Sales Quantity by Region: 2018 VS 2022 VS 2034 (K MT)
Table 11. Global Imatinib Drugs Sales by Region (2018-2024) & (K MT)
Table 12. Global Imatinib Drugs Sales Market Share by Region (2018-2024)
Table 13. Global Imatinib Drugs Sales by Region (2024-2034) & (K MT)
Table 14. Global Imatinib Drugs Sales Market Share by Region (2024-2034)
Table 15. Global Imatinib Drugs Sales Quantity by Manufacturers (2018-2024) & (K MT)
Table 16. Global Imatinib Drugs Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Imatinib Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Imatinib Drugs Revenue Share by Manufacturers (2018-2024)
Table 19. Global Imatinib Drugs Price by Manufacturers 2018-2024 (USD/MT)
Table 20. Global Key Players of Imatinib Drugs, Industry Ranking, 2021 VS 2022
Table 21. Global Imatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Imatinib Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Imatinib Drugs as of 2022)
Table 23. Global Key Manufacturers of Imatinib Drugs, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Imatinib Drugs, Product Offered and Application
Table 25. Global Key Manufacturers of Imatinib Drugs, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 28. Global Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 29. Global Imatinib Drugs Sales Quantity Share by Type (2018-2024)
Table 30. Global Imatinib Drugs Sales Quantity Share by Type (2024-2034)
Table 31. Global Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Imatinib Drugs Revenue Share by Type (2018-2024)
Table 34. Global Imatinib Drugs Revenue Share by Type (2024-2034)
Table 35. Imatinib Drugs Price by Type (2018-2024) & (USD/MT)
Table 36. Global Imatinib Drugs Price Forecast by Type (2024-2034) & (USD/MT)
Table 37. Global Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 38. Global Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 39. Global Imatinib Drugs Sales Quantity Share by Application (2018-2024)
Table 40. Global Imatinib Drugs Sales Quantity Share by Application (2024-2034)
Table 41. Global Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Imatinib Drugs Revenue Share by Application (2018-2024)
Table 44. Global Imatinib Drugs Revenue Share by Application (2024-2034)
Table 45. Imatinib Drugs Price by Application (2018-2024) & (USD/MT)
Table 46. Global Imatinib Drugs Price Forecast by Application (2024-2034) & (USD/MT)
Table 47. North America Imatinib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Imatinib Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 49. North America Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 50. North America Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 51. North America Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 54. North America Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 55. North America Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Imatinib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Imatinib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Imatinib Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 61. North America Imatinib Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 62. Europe Imatinib Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 63. Europe Imatinib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 65. Europe Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 66. Europe Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 69. Europe Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 70. Europe Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Imatinib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Imatinib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Imatinib Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 76. Europe Imatinib Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 77. China Imatinib Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 78. China Imatinib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 80. China Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 81. China Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 84. China Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 85. China Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Imatinib Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 88. APAC Imatinib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 90. APAC Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 91. APAC Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 94. APAC Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 95. APAC Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Imatinib Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Imatinib Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Imatinib Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Imatinib Drugs Sales Quantity by Region (2018-2024) & (K MT)
Table 101. APAC Imatinib Drugs Sales Quantity by Region (2024-2034) & (K MT)
Table 102. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Company (2018-2024) & (K MT)
Table 103. Middle East, Africa and Latin America Imatinib Drugs Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Type (2018-2024) & (K MT)
Table 105. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Type (2024-2034) & (K MT)
Table 106. Middle East, Africa and Latin America Imatinib Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Imatinib Drugs Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Application (2018-2024) & (K MT)
Table 109. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Application (2024-2034) & (K MT)
Table 110. Middle East, Africa and Latin America Imatinib Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Imatinib Drugs Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Imatinib Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Imatinib Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Imatinib Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Country (2018-2024) & (K MT)
Table 116. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity by Country (2024-2034) & (K MT)
Table 117. Apotex Inc. Company Information
Table 118. Apotex Inc. Description and Overview
Table 119. Apotex Inc. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 120. Apotex Inc. Imatinib Drugs Product and Services
Table 121. Apotex Inc. Imatinib Drugs SWOT Analysis
Table 122. Apotex Inc. Recent Developments
Table 123. Novartis Company Information
Table 124. Novartis Description and Overview
Table 125. Novartis Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 126. Novartis Imatinib Drugs Product and Services
Table 127. Novartis Imatinib Drugs SWOT Analysis
Table 128. Novartis Recent Developments
Table 129. Sanofi S.A. Company Information
Table 130. Sanofi S.A. Description and Overview
Table 131. Sanofi S.A. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 132. Sanofi S.A. Imatinib Drugs Product and Services
Table 133. Sanofi S.A. Imatinib Drugs SWOT Analysis
Table 134. Sanofi S.A. Recent Developments
Table 135. Cipla Inc. Company Information
Table 136. Cipla Inc. Description and Overview
Table 137. Cipla Inc. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 138. Cipla Inc. Imatinib Drugs Product and Services
Table 139. Cipla Inc. Imatinib Drugs SWOT Analysis
Table 140. Cipla Inc. Recent Developments
Table 141. Mylan Pharms Inc. Company Information
Table 142. Mylan Pharms Inc. Description and Overview
Table 143. Mylan Pharms Inc. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 144. Mylan Pharms Inc. Imatinib Drugs Product and Services
Table 145. Mylan Pharms Inc. Imatinib Drugs SWOT Analysis
Table 146. Mylan Pharms Inc. Recent Developments
Table 147. Glenmark Pharmaceuticals Ltd. Company Information
Table 148. Glenmark Pharmaceuticals Ltd. Description and Overview
Table 149. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 150. Glenmark Pharmaceuticals Ltd. Imatinib Drugs Product and Services
Table 151. Glenmark Pharmaceuticals Ltd. Imatinib Drugs SWOT Analysis
Table 152. Glenmark Pharmaceuticals Ltd. Recent Developments
Table 153. Sun Pharmaceuticals Company Information
Table 154. Sun Pharmaceuticals Description and Overview
Table 155. Sun Pharmaceuticals Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 156. Sun Pharmaceuticals Imatinib Drugs Product and Services
Table 157. Sun Pharmaceuticals Imatinib Drugs SWOT Analysis
Table 158. Sun Pharmaceuticals Recent Developments
Table 159. Actavis Generics Company Information
Table 160. Actavis Generics Description and Overview
Table 161. Actavis Generics Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 162. Actavis Generics Imatinib Drugs Product and Services
Table 163. Actavis Generics Imatinib Drugs SWOT Analysis
Table 164. Actavis Generics Recent Developments
Table 165. Dr. Reddy's Laboratories Company Information
Table 166. Dr. Reddy's Laboratories Description and Overview
Table 167. Dr. Reddy's Laboratories Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 168. Dr. Reddy's Laboratories Imatinib Drugs Product and Services
Table 169. Dr. Reddy's Laboratories Imatinib Drugs SWOT Analysis
Table 170. Dr. Reddy's Laboratories Recent Developments
Table 171. Teva Pharmaceutical Industries Ltd. Company Information
Table 172. Teva Pharmaceutical Industries Ltd. Description and Overview
Table 173. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Sales Quantity (K MT), Revenue (US$ Million), Average Selling Price (ASP) (USD/MT) and Gross Margin (2018-2024)
Table 174. Teva Pharmaceutical Industries Ltd. Imatinib Drugs Product and Services
Table 175. Teva Pharmaceutical Industries Ltd. Imatinib Drugs SWOT Analysis
Table 176. Teva Pharmaceutical Industries Ltd. Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Imatinib Drugs Distributors List
Table 180. Imatinib Drugs Customers List
Table 181. Imatinib Drugs Market Trends
Table 182. Imatinib Drugs Market Drivers
Table 183. Imatinib Drugs Market Challenges
Table 184. Imatinib Drugs Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Imatinib Drugs Product Picture
Figure 2. Global Imatinib Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Imatinib Drugs Market Share by Type in 2022 & 2034
Figure 4. Capsules Product Picture
Figure 5. Tablets Product Picture
Figure 6. Global Imatinib Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Imatinib Drugs Market Share by Application in 2022 & 2034
Figure 8. Hospitals
Figure 9. Drug Stores
Figure 10. Others
Figure 11. Imatinib Drugs Report Years Considered
Figure 12. Global Imatinib Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Imatinib Drugs Revenue 2018-2034 (US$ Million)
Figure 14. Global Imatinib Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Imatinib Drugs Sales Quantity 2018-2034 (K MT)
Figure 16. Global Imatinib Drugs Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Imatinib Drugs Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Imatinib Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 19. North America Imatinib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Imatinib Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 21. Europe Imatinib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Imatinib Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 23. China Imatinib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Imatinib Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 25. APAC Imatinib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity YoY (2018-2034) & (K MT)
Figure 27. Middle East, Africa and Latin America Imatinib Drugs Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Imatinib Drugs Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Imatinib Drugs Revenue in 2022
Figure 30. Imatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 33. Global Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 35. North America Imatinib Drugs Revenue Market Share by Company in 2022
Figure 36. North America Imatinib Drugs Sales Quantity Market Share by Company in 2022
Figure 37. North America Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 39. North America Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 41. North America Imatinib Drugs Revenue Share by Country (2018-2034)
Figure 42. North America Imatinib Drugs Sales Quantity Share by Country (2018-2034)
Figure 43. U.S. Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Imatinib Drugs Sales Quantity Market Share by Company in 2022
Figure 46. Europe Imatinib Drugs Revenue Market Share by Company in 2022
Figure 47. Europe Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 49. Europe Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 51. Europe Imatinib Drugs Revenue Share by Country (2018-2034)
Figure 52. Europe Imatinib Drugs Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 54. France Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 58. China Imatinib Drugs Sales Quantity Market Share by Company in 2022
Figure 59. China Imatinib Drugs Revenue Market Share by Company in 2022
Figure 60. China Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 62. China Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 64. APAC Imatinib Drugs Sales Quantity Market Share by Company in 2022
Figure 65. APAC Imatinib Drugs Revenue Market Share by Company in 2022
Figure 66. APAC Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 68. APAC Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 70. APAC Imatinib Drugs Revenue Share by Region (2018-2034)
Figure 71. APAC Imatinib Drugs Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 76. India Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Imatinib Drugs Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Imatinib Drugs Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Imatinib Drugs Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Imatinib Drugs Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Imatinib Drugs Revenue Share by Country (2018-2034)
Figure 85. Brazil Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Imatinib Drugs Revenue (2018-2034) & (US$ Million)
Figure 90. Imatinib Drugs Value Chain
Figure 91. Imatinib Drugs Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed